Melanie Senior

Senior Writer & Analyst at Nature Portfolio; Evaluate Pharma

Speaker

Melanie writes about science, strategy, investment and market access for Evaluate Pharma, Nature Biotechnology, IN VIVO and other publications. She also supports international biopharmaceutical companies and associations in clearly communicating their mission and market positioning.

After beginning her career at the London Financial Times, Melanie became Bureau Chief, Europe, for Elsevier Business Intelligence. She worked as a reimbursement and pricing analyst for Real Endpoints in the US and was part of EY Life Sciences’ thought leadership team between 2014-2017.

Melanie holds a First class degree in Natural Sciences (biochemistry) from Cambridge University and has post-graduate qualifications in Sports Physiology & Nutrition (St Mary’s University) and in International Health Technology Assessment (University of Sheffield). She is based in London, UK.